Expression of interferon-γ in human adrenal gland and kidney tumours

被引:0
作者
Q Li
X-q Zhang
L Nie
G-s Chen
H Li
F Zhang
L-y Zhang
L Hong
S-f Wang
H Wang
机构
[1] Xijing Hospital,State Key Laboratory of Cancer Biology and Department of Pathology
[2] Fourth Military Medical University Xi'an,Department of Medical Biochemistry and Microbiology
[3] Box 582,Department of Urinary Surgery
[4] Biomedical Center,undefined
[5] Xijing Hospital,undefined
[6] Fourth Military Medical University Xi'an,undefined
来源
British Journal of Cancer | 2007年 / 97卷
关键词
interferon-; adrenal tumour; clear cell renal cell carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
It is known that interferon-γ (IFN-γ) is produced by activated T and NK lymphoid cells, mononuclear cells, and macrophage and dendritic cells. Our previous studies have shown that IFN-γ-like immunoreactivity also appears in human adrenal cortical tumour and phaeochromocytoma. To investigate whether human tumour cells can produce IFN-γ, we examined 429 biopsy specimens of 30 kinds of tumour and tumour-surrounding tissues in adrenal glands and in kidneys by using immunohistochemistry and in situ hybridisation. IFN-γ immunoactivity was shown in 34.3% of the adrenal cortical adenomas, 50% of the adrenal cortical carcinomas, 26.7% of the phaeochromocytomas, 26.7% of the clear cell renal cell carcinomas (RCCs), 22% of the adrenal cortexes and 40% of medullas adjacent to tumours. The positive samples and expression areas were well overlapped between the IFN-γ mRNA and the immunohistochemistry staining. Western blot analysis has further confirmed the immunohistochemistry results by showing a distinct IFN-γ band corresponding to 17.4 kDa in tissue extracts from adrenal cortical adenoma, phaeochromocytoma and clear cell RCCs. These results indicate that IFN-γ is produced by some types of tumour cells, suggesting it may play a dual role in the development of these tumours.
引用
收藏
页码:420 / 425
页数:5
相关论文
共 50 条
[31]   Interferon alpha receptors are important for antiproliferative effect of interferon-α against human hepatocellular carcinoma cells [J].
Damdinsuren, Bazarragchaa ;
Nagano, Hiroaki ;
Wada, Hiroshi ;
Noda, Takehiro ;
Natsag, Javzandulam ;
Marubashi, Shigeru ;
Miyamoto, Atsushi ;
Takeda, Yutaka ;
Umeshita, Koji ;
Doki, Yuichiro ;
Dono, Keizo ;
Monden, Morito .
HEPATOLOGY RESEARCH, 2007, 37 (01) :77-83
[32]   Interferon-β is more potent than interferon-α in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs [J].
Damdinsuren, B ;
Nagano, H ;
Sakon, M ;
Kondo, M ;
Yamamoto, T ;
Umeshita, K ;
Dono, K ;
Nakamori, S ;
Monden, M .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (10) :1184-1190
[33]   Mutations of K-ras oncogene in human adrenal tumours in Taiwan [J].
Lin, SR ;
Tsai, JH ;
Yang, YC ;
Lee, SC .
BRITISH JOURNAL OF CANCER, 1998, 77 (07) :1060-1065
[34]   Human interferon-ε and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R [J].
Harris, Bethany D. ;
Schreiter, Jessica ;
Chevrier, Marc ;
Jordan, Jarrat L. ;
Walter, Mark R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (41) :16057-16068
[35]   Microcalorimetric studies of the effects on the interactions of human recombinant interferon-α2a [J].
Huang, SL ;
Lin, FY ;
Yang, CP .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (05) :545-552
[36]   Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression [J].
Seung-Hoon Lee ;
Jung-Whan Kim ;
Han-Woong Lee ;
Yong-Suk Cho ;
Sun-Hee Oh ;
Yong-Jin Kim ;
Chul-Ho Jung ;
Wei Zhang ;
Je-Ho Lee .
Oncogene, 2003, 22 :381-391
[37]   Production and characterization of thirteen human type-I interferon-α Mark subtypes [J].
Kuruganti, Srilalitha ;
Accavitti-Loper, Mary Ann ;
Walter, Mark R. .
PROTEIN EXPRESSION AND PURIFICATION, 2014, 103 :75-83
[38]   Affinity adsorption of recombinant human interferon-α on a porous dye-affinity adsorbent [J].
Karakoç, V ;
Yavuz, H ;
Denizli, A .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2004, 240 (1-3) :93-99
[39]   Effect of recombinant interferon-α2b (Laferon) on human neuroblastoma cells [J].
V. V. Kucher ;
G. Kh. Matsuka ;
O. M. Rozhmanova ;
E. V. Dolgaya ;
L. N. Stelmakh ;
N. Kh. Pogorelaya .
Neurophysiology, 2000, 32 :226-227
[40]   Effect of recombinant interferon-α2b (laferon) on human neuroblastoma cells [J].
Kucher, VV ;
Matsuka, GK ;
Rozhmanova, OM ;
Dolgaya, EV ;
Stelmakh, LN ;
Pogorelaya, NK .
NEUROPHYSIOLOGY, 2000, 32 (03) :226-227